文献速递介入腹部CT

肝细胞癌经皮微波消融:100 W与150 W技术系统的比较

Percutaneous microwave ablation of HCC: comparison between 100 and 150 W technology systems.
PubMed 文献 · Radiol Med · 2024-11-08

该回顾性研究纳入87例患者共135个肝细胞癌结节,比较100 W与150 W经皮微波消融系统的疗效与安全性。150 W组消融时间更短、消融体积更大、1个月CT随访主要有效性更高,但II-III级并发症发生率也更高。作者认为这些初步结果显示两组计划治疗区与消融体积及消融时间均有良好相关性。

要点

  • 150 W系统消融时间更短(平均227.37±92.5 s vs 180.51±75.6 s,100 W vs 150 W,p=0.002)。
  • 150 W系统消融体积更大(平均13,920.0±10,723.2 mm³ vs 21,241.4±18,374.7 mm³,100 W vs 150 W,p=0.008)。
  • 150 W组1个月CT随访主要有效性更高(p=0.013),但II-III级并发症发生率更高(p<0.001)。

核心结论

  • 150 W组消融时间更短、消融体积更大、1个月CT随访主要有效性更高,但并发症发生率更高;两组计划治疗区与消融体积及消融时间均显示良好相关性。

研究设计与样本

  • 回顾性研究,纳入2021年1月至2023年5月接受经皮微波消融(Emprint™ HP Ablation System,Medtronic)的87例患者共135个肝细胞癌结节,中位年龄66±10岁;第1组42例患者76次操作使用100 W系统,第2组45例患者59次操作使用150 W系统;有效性定义为1个月CT随访无残留病灶,安全性定义为无II-VI级并发症。

诊断标准与关键数值

  • 有效性定义为1个月CT随访无残留病灶;安全性定义为无II-VI级并发症;150 W组消融时间平均180.51±75.6 s vs 100 W组227.37±92.5 s(p=0.002);150 W组消融体积平均21,241.4±18,374.7 mm³ vs 100 W组13,920.0±10,723.2 mm³(p=0.008);150 W组1个月CT随访主要有效性更高(p=0.013);150 W组II-III级并发症发生率更高(p<0.001)。

临床应用与阅片要点

  • 作者认为这些初步结果显示两组计划治疗区与消融体积及消融时间均有良好相关性;150 W组消融时间更短、消融体积更大、1个月CT随访主要有效性更高,但II-III级并发症发生率也更高。

局限性

  • 原文自述为初步结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To evaluate the differences in efficacy and safety between the 100 and 150 W percutaneous microwave ablation (MWA) systems in the treatment of hepatocellular carcinoma (HCC).

METHODS: We retrospectively reviewed all patients who underwent percutaneous MWA (Emprint™ HP Ablation System, Medtronic) between January 2021 and May 2023. We divided the cohort into two groups: Group 1, treated with MWA at 100 W power system, and Group 2, treated with 150 W one. Effectiveness was defined as the absence of residual disease at 1-month CT follow-up; safety was defined as the absence of grade II-VI complications.

RESULTS: A total of 135 HCC nodules were treated with MWA in 87 patients with a median age of 66 ± 10 years: 76 procedures in 42 patients were carried out in group 1, while 59 procedures in 45 patients in group 2. Cases treated with 150 W had a shorter ablation time (p: 0.002; mean 227.37 ± 92.5 vs 180.51 ± 75.6 s (100 vs 150 W)) and a larger ablation volume (p 0.008; mean 13,920.0 ± 10,723.2 vs 21,241.4 ± 18,374.7 mm3 (100 vs 150 W)), and a major effectiveness at 1-month CT follow-up (p: 0.013). A higher rate of complications (grade II and III) was observed in Group 2 (p < 0.001).

CONCLUSIONS: In conclusion, these preliminary results showed a good correlation between intended-to-treat area and ablation volume and intended-to-treat area and ablation time for both Groups. A minor ablation time, and major ablation volume, but also a higher incidence of complications was observed in 150 W Group.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Lanza C, Angileri SA, Biondetti P, et al. Percutaneous microwave ablation of HCC: comparison between 100 and 150 W technology systems. Radiol Med. 2024. PMID: 39514155. doi:10.1007/s11547-024-01927-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。